89bio, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
89bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • 89bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.17M, a 24.9% increase year-over-year.
  • 89bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $18.6M, a 43.6% increase year-over-year.
  • 89bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $16.1M, a 55.5% increase from 2022.
  • 89bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.4M, a 19.3% increase from 2021.
  • 89bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.68M, a 128% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.1M +$5.75M +55.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 $10.4M +$1.68M +19.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 $8.68M +$4.87M +128% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-01
2020 $3.81M +$3.42M +879% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $389K +$281K +260% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $108K Jan 18, 2018 Dec 31, 2018 10-K 2020-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.